Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 9.80
+0.05 (0.51%)
Jul 27, 2026, 4:27 PM GMT
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 42.85 million as of July 27, 2026. Its market cap has increased by 82.38% in one year.
Market Cap
42.85M
Enterprise Value
40.10M
Revenue
9.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.80
ChartMarket Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 42.85M, a decrease of -57.55%. That is a compound annual growth rate of -14.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 42.85M | 54.50% |
| Dec 31, 2025 | 27.74M | -7.08% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.51B |
| GSK plc | 76.44B |
| Haleon | 32.02B |
| Smith & Nephew | 9.59B |
| Kooth | 56.76M |
| hVIVO | 51.53M |
| Hemogenyx Pharmaceuticals | 49.44M |
| Poolbeg Pharma | 46.95M |